Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
KUO, MACUS T
One or more keywords matched the following items that are connected to KUO, MACUS T
Item TypeName
Concept Arginine
Academic Article Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4.
Academic Article Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells.
Academic Article Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma.
Academic Article Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.
Academic Article Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase.
Academic Article TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation.
Academic Article Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction.
Academic Article Arginine deprivation as a targeted therapy for cancer.
Academic Article Arginine deprivation in cancer therapy.
Academic Article Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin.
Academic Article Gas6/Axl in arginine-starvation therapy.
Academic Article Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin
Academic Article Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents
Academic Article Arginine Deiminase and Cancer Therapy
Academic Article Gas6/Axl in arginine-starvation therapy
Academic Article Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation
Academic Article BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma
Academic Article Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy
Academic Article Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents.
Academic Article BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma.
Academic Article Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1a, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation.
Academic Article Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy.
Academic Article Degradation of AMPK-a1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivation.
Academic Article Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1a Degradation at the ASS1 promoter for ASS1 Derepression.
Academic Article Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors.
Academic Article Targeting the Proline-Glutamine-Asparagine-Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy.
Academic Article Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma.
Search Criteria
  • Arginine